BioClonetics has been granted 4 U.S. patents and 1 European patent on the Clone 3hybridoma cell line, anti-gp41 human monoclonal antibody and the use of the Clone3 epitope in the production of a vaccine against HIV/AIDS. https://www.academia.edu/9761133/BioClonetics_Incorporated_Dr_Joseph_Cotropia